Physitrack offers a complete solution for digitalised healthcare that includes testing, prevention and consultation, but with a subscription basis and with a focus on physiotherapy. The solution is offered in apps and online through different brands, which in turn can be divided into two segments – the SaaS platform and the Virtual Care offering. Moreover, the company offers technology for preventive care and education for physiotherapists. The strategic plan is to expand geographically, enter new verticals, and drive sales growth through M&A.
Increased demand for remote and flexible care, in combination with the digitalisation of healthcare, should result in strong demand for Physitrack’s products. The scalability of the technology platform also allows for margin expansion. Additionally, there are opportunities in cross-selling synergies and value-added M&A opportunities.
We see market competition as the main risk to Physitrack. The company could be challenged by other players in terms of market share and price pressure, which could lead to lower profitability and reduced growth. There is also a risk of increased competition for acquisition targets, which could challenge the M&A strategy. Other risks that Physitrack is exposed to include acquisitions that might not develop as expected, currency fluctuations, and risks related to personal data.